- Celiac Disease
- About Us
- Pipeline & Trials
- News & Events
We invite you to share in our latest research and developments on celiac disease and refractory celiac disease (refractory sprue), through the scientific publications and presentations of Celimmune.
Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.Comino I, Fernández-Bañares F, Esteve M … León F, Marinich J, Muñoz-Suano A, Cebolla A, Sousa C. American Journal of Gastroenterology. 2016;111:1456-1465.
Morena, ML, Cebolla Á, Muñoz-Suano A, Carrillo-Carrion C, Comino I, Pizarro Á, León F, Rodríguez-Herrera A, Sousa C. Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing. Gut 2015;0:1-8.
Gorski KS, Butz EA, Lebrec H, Leon F, Tsuji WH. The Fully Human Anti-IL-15 Antibody AMG 714, in Development for Celiac and Refractory Celiac Disease, Does Not Reduce Circulating Numbers of Human Natural Killer Cells or Preclude Their In Vitro Activation and Function. Digestive Disease Week. San Diego. May 2016
Moreno Amador ML, Cebolla Ramírez A, Muñoz Suano A, Carrillo Carrión C, Comino Montilla I, Pizarro Moreno A, Leon F et al. Dietary transgressions in celiac disease can be revealed by detection of gluten peptides in urine. 12th European Nutrition Conference FENS. Berlin, Germany. October 2015.
Moreno Amador ML, Cebolla Ramírez A, Muñoz Suano A, Carrillo Carrión C, Comino Montilla I, Pizarro Moreno A, León F, et al. Detection of gluten peptides in urine of celiac patients: correlation with mucosal damage. United European Gastroenterology Week. Barcelona, Spain. October 2015.
Leon F, Lebrec H, Tsuji W. Rationale for AMG 714, an anti-IL-15 mAb, in the treatment of celiac and refractory celiac disease. 16th International Celiac Disease Symposium. Prague, Czech Republic. June 2015.